Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
The exact stability of any peptide depends on factors such as its amino acid sequence, formulation, storage conditions, handling practices, and the diluent used during reconstitution
They may be a good option if you want a quick visit without a full IV drip
painful and acid reflux like crazy
Research indicates that the peptide may: Increase fat breakdown Improve energy use from stored fat Support gradual weight reduction However, it is important to understand that AOD-9604 is not a miracle fat-loss compound